SlateStone Wealth’s Neos Therapeutics, Inc NEOS Stock Holding History

SlateStone Wealth’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-62,000	Closed	-$39K	–	180
2020 Q4	$39K	Hold	62,000	–	–	0.01%	169
2020 Q3	$33K	Buy	+62,000	New	+$42.1K	0.01%	174

SlateStone Wealth's NEOS Position: Q1 2021 in Review

SlateStone Wealth sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 62,000 shares — an estimated $39K sold.

SlateStone Wealth first reported a position in NEOS in Q3 2020 and held it in 2 quarters. The position peaked at $39K in Q4 2020. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.

SlateStone Wealth reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
SlateStone Wealth sold 62,000 Neos Therapeutics, Inc shares in Q1 2021, an estimated $39K.
SlateStone Wealth first reported a position in Neos Therapeutics, Inc in Q3 2020 and held it in 2 quarters.
SlateStone Wealth's Neos Therapeutics, Inc position peaked at $39K in Q4 2020.
0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.

Based on SlateStone Wealth's 13F filing for Q1 2021, filed 19 Apr 2021.